StoxGud Sign in
20

Vivo Bio Tech Limited

NSE: VIVOBIOT · Unclassified

₹14.65-0.75%06 Nov 2026

Ask the data

Instant answers about Vivo Bio Tech Limited — computed from its filings, no language model
Market cap₹14 cr
Current price₹14.65
High / Low₹20 / ₹13
P/E—
P/B—
Book value—
ROE—
ROCE—
Debt / equity—
Dividend yield—
EPS (TTM)₹-3.35
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
showing latest 6 of 16 periods
FY11†FY12†FY13†FY14†FY15†FY16†FY17†FY18†FY19†FY20†FY21†FY22†FY23†FY24†FY25†FY26†
Revenue9.112.514.416.117.828.634.147.055.855.451.851.451.644.946.752.6
EBITDA4.75.21.91.82.83.77.610.913.312.517.715.821.521.120.821.2
Operating margin51.8%41.9%12.9%10.9%15.7%13.0%22.4%23.1%23.8%22.5%34.1%30.8%41.6%47.0%44.6%40.4%
Interest2.73.50.8—0.50.51.32.42.63.13.54.07.67.87.55.8
Depreciation2.62.4—1.63.03.43.94.75.15.25.67.49.39.39.010.6
Profit before tax-0.5-0.60.80.70.20.82.84.01.84.28.64.54.64.19.14.6
Tax-0.3-0.3-0.50.4-0.3-0.10.30.9-0.4-0.22.92.32.01.51.56.5
Net profit-0.2-0.31.20.30.50.92.53.12.24.45.72.22.62.57.6-1.9

Quarterly performance

last 73 quarters · ₹ crore
showing latest 8 of 73 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†JUN '09†SEP '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†MAR '12†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†MAR '18†JUN '18†SEP '18†DEC '18†MAR '19†JUN '19†SEP '19†DEC '19†MAR '20†JUN '20†SEP '20†DEC '20†MAR '21†JUN '21†SEP '21†DEC '21†MAR '22†JUN '22†SEP '22†DEC '22†MAR '23†JUN '23†SEP '23†DEC '23†MAR '24†JUN '24†SEP '24†DEC '24†MAR '25†JUN '25†SEP '25†DEC '25†MAR '26†JUN '26†
Revenue0.00.00.00.00.00.0—2.51.52.32.42.83.33.33.02.93.93.23.63.74.03.64.54.13.73.54.66.06.07.37.97.38.28.98.58.611.011.612.112.313.614.114.413.813.313.514.114.49.214.711.916.113.010.212.915.311.312.513.414.411.69.012.711.610.112.012.212.312.413.013.413.814.1
Operating profit-0.2-0.3-0.4-0.3-0.40.0-1.61.00.61.91.01.21.91.41.10.90.90.50.5-0.00.40.50.50.40.20.50.51.71.21.00.90.71.22.32.51.52.32.73.22.73.63.93.22.53.83.73.81.22.96.04.84.04.63.85.81.64.84.74.97.14.64.86.45.34.45.75.65.15.55.45.54.85.0
Operating margin-2400.0%-1650.0%-1333.3%-1033.3%-1233.3%50.0%—39.2%39.5%79.4%41.7%44.2%56.4%41.8%35.2%32.6%24.3%14.8%12.4%-0.3%11.1%12.6%10.4%9.6%4.4%12.9%10.6%28.4%19.2%13.9%11.1%9.0%14.9%26.1%30.0%18.0%21.2%23.5%26.2%21.6%26.6%27.8%22.4%18.4%28.3%27.1%26.9%8.6%31.6%40.8%40.2%24.9%35.5%37.7%44.6%10.5%42.5%37.2%36.8%49.3%39.7%52.9%50.2%46.1%43.2%47.1%45.9%41.8%44.5%41.6%41.1%34.7%35.7%
Other income———————0.6—0.1—0.0—0.00.0————0.70.20.20.20.30.20.20.20.30.20.30.10.30.20.1—0.00.1——0.00.0————0.0—0.0———0.10.20.0—-0.10.00.00.00.0——0.00.00.04.60.00.10.10.10.10.00.1
Interest—0.1—0.00.1——0.40.60.80.60.70.80.80.81.00.70.00.00.0—0.10.10.20.10.10.10.20.10.10.10.10.10.10.60.50.50.60.60.60.70.70.70.60.90.80.70.80.71.00.51.20.91.11.20.91.81.82.12.01.92.12.21.51.92.11.81.71.51.51.41.51.2
Depreciation0.00.00.10.00.00.00.20.31.10.50.50.60.70.70.80.20.50.30.3—0.40.40.40.30.40.40.51.80.80.90.80.90.81.01.01.11.21.11.40.91.21.31.41.31.31.31.41.21.31.31.31.81.81.71.72.22.32.42.32.32.32.32.32.42.22.32.22.22.62.62.72.83.5
Profit before tax-0.3-0.5-0.5-0.4-0.50.0-1.80.8-1.10.7-0.1-0.00.3-0.2-0.5-0.2-0.30.20.10.70.20.20.10.2-0.10.10.10.10.50.20.1-0.10.51.41.0-0.10.81.01.11.11.81.91.2-3.11.61.71.7-0.70.93.72.91.12.21.12.8-1.60.70.50.62.90.40.41.91.40.26.01.51.41.51.51.6-0.00.3
Tax0.00.00.00.00.00.00.10.0-0.1-0.1-0.1-0.0-0.1-0.1-0.1-0.1-1.00.00.00.50.10.00.00.30.00.00.0-0.30.10.10.0-0.40.10.20.2-0.30.10.10.30.30.3-0.5-0.0-0.20.4-0.70.3-0.3-0.11.50.70.80.90.81.5-0.90.40.40.40.80.10.10.60.70.10.60.60.20.10.60.35.40.1
Net profit-0.3-0.5-0.5-0.4-0.50.0-1.90.8-1.00.8-0.00.00.4-0.1-0.4-0.10.70.20.10.20.10.20.1-0.1-0.10.10.10.40.30.20.10.30.41.20.70.20.70.90.80.81.52.51.3-3.01.22.31.3-0.41.02.22.20.31.20.31.4-0.70.30.10.22.00.30.21.30.70.25.30.91.21.40.91.3-5.40.2
EPS ₹-0.28-0.52-0.50-0.40-0.58—-1.980.83—0.89-0.010.010.41-0.12-0.45-0.150.760.210.100.270.160.180.09-0.11-0.140.110.080.440.360.190.110.320.431.240.780.240.700.940.810.821.502.481.27-2.410.941.831.02-0.310.761.671.750.220.870.200.97-0.480.220.080.111.370.170.160.890.470.123.560.600.000.000.000.000.000.00
Revenue YoY————200.0%-33.3%——7500.0%——11.0%115.8%40.8%25.6%1.8%19.2%-3.0%19.4%28.1%1.0%12.6%24.8%10.0%-7.1%-2.5%2.4%47.3%64.9%108.3%70.5%22.9%35.2%22.7%7.2%16.3%34.0%30.5%42.3%44.2%23.9%20.9%19.5%11.7%-1.7%-3.8%-2.1%4.3%-31.5%8.3%-15.8%12.0%42.0%-30.6%8.8%-4.8%-13.3%23.2%3.9%-5.9%2.8%-27.9%-5.3%-19.8%-12.5%33.2%-3.9%6.4%22.6%8.1%9.5%12.0%13.8%
Profit YoY———————————-98.7%—-113.3%—-1500.0%82.1%———-78.9%-10.5%-20.0%-144.0%-186.7%-35.3%0.0%——54.5%25.0%-26.8%17.6%582.4%630.0%-26.7%65.0%-24.1%2.7%263.6%125.8%180.7%68.0%-472.5%-19.5%-5.7%4.0%—-18.3%-7.3%71.8%—25.5%-87.0%-39.1%-326.7%-74.0%-57.1%-88.3%—-18.8%108.3%725.0%-65.7%-30.8%2024.0%-32.6%70.0%661.1%-83.6%41.6%-557.1%-86.9%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 65 periods
JUN '08SEP '08DEC '10MAR '11JUN '11SEP '11DEC '11MAR '12JUN '12SEP '12DEC '12MAR '13JUN '13SEP '13DEC '13MAR '14JUN '14SEP '14DEC '14MAR '15JUN '15SEP '15DEC '15MAR '16JUN '16SEP '16DEC '16MAR '17JUN '17SEP '17DEC '17MAR '18JUN '18SEP '18DEC '18MAR '19JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
Net margin-1755.6%-1690.9%6.6%-2.1%11.2%2.4%-1.0%-2.2%0.3%2.6%6.3%8.7%4.8%4.5%4.1%1.8%0.1%-0.3%-0.3%2.6%4.7%4.2%3.7%3.2%3.2%6.1%7.9%7.4%7.5%6.3%5.8%6.6%7.9%10.6%11.1%4.0%3.5%3.3%3.4%8.0%8.2%7.7%10.0%11.0%10.7%7.9%6.1%4.3%2.6%2.2%-0.2%5.1%5.0%5.6%8.1%5.6%5.6%16.2%15.4%16.2%17.9%8.7%9.2%-3.7%-5.8%
EBITDA margin-1422.2%-1281.8%50.6%51.8%54.9%46.4%44.6%41.9%33.0%26.4%20.7%12.9%9.3%9.0%8.6%10.9%9.3%9.3%9.4%15.7%18.8%18.2%17.5%13.0%12.3%15.7%20.5%22.4%23.7%23.1%22.6%23.1%24.5%25.6%24.7%23.8%24.2%24.0%25.2%22.5%22.6%26.6%29.7%34.1%34.9%33.7%34.9%30.8%32.2%32.3%30.4%41.6%41.0%44.2%47.9%47.0%48.1%46.9%45.7%44.6%44.8%43.4%42.2%40.4%38.2%
Interest coverage——1.120.811.301.000.880.830.650.690.901.99————1.711.551.551.372.572.802.922.702.765.484.073.202.872.232.242.682.963.283.331.691.591.491.632.382.212.733.233.453.692.962.642.121.611.431.021.601.551.511.671.521.512.232.242.212.461.911.991.781.61

Balance sheet

equity vs borrowings over time · ₹ crore

Not filed yet.

Cash flow

annual · ₹ crore · line = free cash flow

Not filed yet.

Where the assets sit

No balance sheet filed yet.

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Vivo Bio Tech Limited1414.65———

StoxGud checklist: Bearish setup · 2/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-3.0%
6 months—
1 year—
3Y CAGR—
5Y CAGR—
10Y CAGR—
50-day avg₹15.94
200-day avg—
RSI (14)52

FAQs

What is the share price of Vivo Bio Tech Limited?

Vivo Bio Tech Limited (VIVOBIOT) closed at ₹14.65 on NSE on 06 Nov 2026.

What is the market cap of Vivo Bio Tech Limited?

₹14 crore at the latest close.

How fast is Vivo Bio Tech Limited growing?

Vivo Bio Tech Limited: revenue has compounded at 0.6% a year over three years. Latest-quarter revenue is up 13.8% year on year, profit down 86.9%.

How profitable is Vivo Bio Tech Limited?

On a trailing-twelve-month basis operating margin 38.2%, net margin -5.8%.

How much debt does Vivo Bio Tech Limited have?

Debt to equity isn't meaningful for Vivo Bio Tech Limited (banks borrow as part of their business) or isn't filed yet.

Vivo Bio Tech Limited's results are not in NSE's XBRL filings, so these are its standalone quarterly results as published on BSE (†), ₹ crore, from SEP '07; full years are summed from the quarters. No balance sheet or cash flow is available from this source. Information only, not investment advice.